Ethris
Uses mRNA technology to develop respiratory treatments; official disclosures report 2022 financing and a strategic investment from Cipla.
GermanyFull profile →
Find your next research lead.
All cataloged profiles, sources, filters, and comparisons are open. Sign in to save companies, keep private notes, and join discussions.
471 company identities · 13 technology & service fields
Disease tags identify mentions in recorded facts or pipeline text, not approved indications or a complete pipeline. Platform service providers may have no disease-specific tag.
2 matching companies
Upperton Pharma Solutions
Offers oral, nasal, pulmonary, and early-stage sterile formulation development, from feasibility and prototypes through scale-up and clinical manufacturing, addressing low solubility and stability challenges.
United KingdomFull profile →
Coverage expands from sourced records; this database does not claim all biopharma companies.